top of page

Eduovisual

Patient Safety & Systems-Based Practice

Discharge planning and readmission prevention

Clinical Overview and When to Suspect High Readmission Risk

— Hospital readmission = unplanned return to inpatient status within 30 days of discharge

— CMS Hospital Readmissions Reduction Program (HRRP) penalizes excess readmissions for AMI, HF, pneumonia, COPD, CABG, and elective THA/TKA

— National 30-day all-cause readmission rate ~14%; costs Medicare >$26 billion annually

— Tests longitudinal thinking: hospital discharge is a high-risk transition of care, not an endpoint

— Roughly 20% of Medicare patients are readmitted within 30 days; nearly half of these are considered preventable

— Most readmissions occur within the first 7–15 days post-discharge — the "post-hospital syndrome" window of physiologic and cognitive vulnerability

— Age ≥75, polypharmacy (≥5 meds), prior hospitalization within 6 months

— Heart failure, COPD, cirrhosis, ESRD on HD, sickle cell disease

— Cognitive impairment, depression, frailty, low health literacy

— Limited social support, housing insecurity, food insecurity, lack of PCP

— Substance use disorder, polysubstance, ongoing opioid therapy

— Discharge to skilled nursing facility (paradoxically higher than home with services in some cohorts)

LACE index (Length of stay, Acuity, Comorbidity, ED visits in prior 6 mo): score ≥10 = high risk

HOSPITAL score: hemoglobin, oncology, sodium, procedure, index admission type, prior admissions, length of stay

— Use on admission, not at discharge, so the care plan can be built around risk

Board pearl: On Step 3, the moment a high-risk patient is admitted, the correct answer often involves initiating discharge planning on day 1 — engaging case management, identifying caregiver, and clarifying goals of care before the acute issue is even fully resolved.

Key distinction: Readmissionrecidivism or failure; the testable construct is preventability through coordinated transitions, not avoidance of legitimate care.

Definition and scope
Why Step 3 cares
High-risk patient archetypes (suspect early on admission)
Validated risk tools
Solid White Background
Presentation Patterns and Key History — the Vulnerable Discharge

— Patient returns 5–12 days after discharge with a different problem than the index admission

— Common returns: dehydration, AKI, falls, delirium, medication adverse events, uncontrolled pain, missed diagnoses

— Deconditioning, sleep deprivation, and nutritional debt from the index stay create a window of generalized vulnerability

Medication reconciliation gaps: "I didn't know which blood pressure pill to keep taking"

Discharge instruction comprehension: ask teach-back — "Tell me in your own words when to call the doctor"

Follow-up appointment: scheduled? transportation? insurance active? PCP accepting?

Equipment and services: home oxygen delivered? home health nurse actually visited? glucometer in hand?

Caregiver status: who is helping with meds, meals, mobility, wound care?

Red-flag symptom recognition: does patient know weight gain ≥3 lb/day = call HF clinic?

HF readmission: dietary indiscretion, diuretic non-adherence, NSAID use, missed weight monitoring

COPD readmission: inhaler technique failure, missed pulmonary rehab, ongoing smoking, no rescue plan

Pneumonia readmission: incomplete antibiotic course, undiagnosed post-obstructive cause, aspiration risk unaddressed

AMI readmission: DAPT non-adherence (cost!), missed cardiac rehab, depression

Cirrhosis readmission: lactulose under-dosing, SBP prophylaxis missed, diuretic-induced AKI

— Screen for transportation, housing, food, utilities, interpersonal safety (CMS-mandated SDOH screening)

— Ask about cost: "Did you fill all your prescriptions?" — primary non-adherence runs 20–30%

Step 3 management: When a recently discharged patient re-presents, the first three questions are: (1) Did you get your medications? (2) Did you keep your follow-up appointment? (3) What did you eat and drink yesterday? These uncover the majority of preventable readmissions before you order a single lab.

The "post-hospital syndrome" presentation
History elements that predict failed discharge
Common driver patterns by index diagnosis
Social history is clinical history
Solid White Background
Discharge Readiness Assessment — the "Exam" of Systems Practice

Cognition: Mini-Cog or 3-item recall before discharge teaching; delirium screen (CAM) within 24 h of discharge

Mobility: observed ambulation, stairs if relevant, Timed Up and Go (>12 sec = fall risk)

ADL/IADL capacity: can the patient self-medicate, prepare meals, manage finances?

Vision and hearing: critical for reading med bottles and hearing instructions

Health literacy: Newest Vital Sign or REALM-SF if formal; otherwise teach-back

— Afebrile ≥24 h, stable vitals ≥8–24 h, oxygenation at or near baseline on room air or stable home O2

— Eating, drinking, voiding, ambulating to baseline (or planned SNF level)

— Pain controlled on the oral regimen patient will go home on — not on IV

— Tolerating oral medications for ≥1 dose cycle

— Bowel function returned (especially post-op, post-opioid initiation)

HF: euvolemic by exam, weight at dry weight, on goal-directed oral diuretic ≥24 h, K+ and Cr stable

COPD: SpO2 ≥88% on prescribed O2, inhaler technique demonstrated, oral steroid taper clear

Pneumonia: meets all 5 clinical stability criteria (HR, RR, BP, SpO2, mental status, PO intake)

DKA: anion gap closed, transitioned to SC insulin with 1–2 h overlap of IV

— Confirmed destination (home, SNF, rehab, shelter, group home)

— Caregiver identified and educated

— Equipment delivered or scheduled

— Prescriptions filled — ideally meds-to-beds at the bedside before discharge

CCS pearl: On a CCS case, do not click "discharge home" until you've ordered: medication reconciliation, follow-up appointment, patient education, and (when applicable) home health services. Premature discharge in CCS is scored as a management error even if clinical parameters look fine.

The functional and cognitive exam at discharge
Physiologic stability checklist (the "vitals" of discharge readiness)
Disease-specific stability triggers
Social readiness
Solid White Background
Discharge Workup — Medication Reconciliation and Documentation

— Performed at three transitions: admission, any level-of-care change, and discharge

— Compare: pre-admission med list, inpatient med list, discharge med list — reconcile every line

— Adverse drug events occur in ~20% of patients within 3 weeks of discharge; ~70% are preventable

— Use a pharmacist whenever possible — pharmacist-led reconciliation reduces readmissions in multiple RCTs

— Drug name (generic and brand), dose, route, frequency, duration, indication

— Explicit STOP list: which prior medications are discontinued and why

— Explicit HOLD list: e.g., hold lisinopril until Cr <1.5, hold metformin until eGFR rechecked

— Explicit NEW list: include why ("new for atrial fibrillation — prevents stroke")

— Reconcile against insurance formulary; substitute if non-covered to prevent primary non-adherence

— Anticoagulants (warfarin INR plan, DOAC renal dosing), insulin, opioids, digoxin

— Antihypertensives (orthostasis risk in elderly), diuretics (electrolyte monitoring plan)

— Antibiotics with specific durations — write the stop date, not just "x 7 days"

— Steroid tapers — write the full schedule with dates

— Must reach the receiving clinician within 48 hours (Joint Commission and CMS expectation)

— Required: admission diagnosis, hospital course, discharge diagnoses, procedures, pending labs/cultures, follow-up appointments, medication changes, code status, functional status

Pending results at discharge are present in ~40% of patients and are a major safety hazard — flag them explicitly and assign ownership

Board pearl: When a vignette describes a patient who returns with hyperkalemia after discharge on a new ACE inhibitor and continued spironolactone — the failure point is medication reconciliation, not the prescribing decision. The answer is institutional med-rec process improvement, often by pharmacist.

Medication reconciliation: the single highest-yield safety intervention
Required elements of the discharge med list
High-risk medication classes requiring extra scrutiny
The discharge summary itself
Solid White Background
Advanced Workup — Risk Stratification Tools and Bundled Interventions

LACE+: adds patient demographics, prior ED use, ICU days — better calibration than LACE

HOSPITAL score: ≥7 = high risk for potentially avoidable readmission

PRA (Probability of Repeated Admission) for Medicare outpatients

— Disease-specific: Seattle Heart Failure Model, BODE index for COPD

Project RED (Re-Engineered Discharge) — Boston Medical Center, 11-component bundle: reduces readmissions ~30%

— Key elements: discharge advocate, after-hospital care plan booklet, follow-up call within 72 h

Project BOOST (Better Outcomes for Older adults through Safe Transitions) — SHM

Care Transitions Intervention (Coleman model) — transition coach, 4 pillars: medication self-management, personal health record, follow-up, red flags

Transitional Care Model (Naylor) — APRN-led, particularly for HF; reduces readmissions and mortality

— Post-discharge phone call within 48–72 hours by nurse or pharmacist — reviews meds, symptoms, appointments

— Remote patient monitoring (weight scales for HF, pulse oximetry for COPD) — variable evidence, useful in selected high-risk patients

— Patient portal messaging and televisit follow-up — now CMS reimbursable

— Community health workers and peer navigators reduce readmissions in safety-net populations

— Hospital-at-home programs (CMS Acute Hospital Care at Home waiver) — for selected stable patients

— Skilled home health: PT/OT, nursing wound care, IV antibiotics via OPAT

Key distinction: A transition of care visit (CPT 99495/99496) is a billable Medicare service requiring contact within 2 business days and face-to-face visit within 7 or 14 days. It is reimbursed at a higher rate than a standard follow-up — testable as a systems-based practice intervention that aligns financial incentives with quality.

Validated readmission risk scores (use on admission day 1)
Evidence-based bundles that reduce readmissions
Telephonic and digital follow-up
Community-based bridges
Solid White Background
Risk Stratification and Building the Discharge Plan

Low risk (young, single problem, intact social support, no high-risk meds): standard discharge instructions, PCP follow-up within 2–4 weeks

Moderate risk (chronic disease, polypharmacy, lives alone): add post-discharge call, follow-up within 7–14 days, consider home health

High risk (LACE ≥10, HF/COPD/cirrhosis, frail, prior 30-day readmission): multidisciplinary bundle, follow-up within 7 days, transition coach, pharmacist med rec

— Discharge planning, complete communication, availability/timeliness of outpatient follow-up, medication safety, patient education, enlisting social support, advance care planning, coordinating care among team members

— Discharge summary completed and sent

— Medication reconciliation finalized with patient teach-back

— Follow-up appointment scheduled (not just "call your doctor") — ideally before patient leaves

— Red-flag symptom list given in writing at appropriate literacy level (5th–6th grade)

— Transportation confirmed

— Equipment delivered or scheduled

— Pending labs/studies documented with responsible clinician

— Patient and caregiver acknowledge understanding via teach-back

— Home with self-care: independent, stable, good support

— Home with home health: needs nursing, PT/OT, or IV therapy but otherwise safe

— SNF: needs 24-hr nursing, rehab potential, Medicare 3-midnight rule (waived under some ACOs)

— Inpatient rehab: ≥3 hours therapy/day tolerated, multiple disciplines needed

— LTACH: prolonged complex medical care (ventilator weaning, complex wounds)

— Hospice: limited prognosis, comfort-focused goals

Step 3 management: A common stem — "78-year-old with new HF exacerbation, lives alone, missed prior appointments, on 9 medications." Best next step is multidisciplinary discharge planning with pharmacist med rec, home health referral, and follow-up within 7 days, not simply discharging on optimized GDMT.

Tiered discharge planning model
The "Ideal Transition" framework (8 domains)
Day-of-discharge checklist
Choosing the discharge destination
Solid White Background
Pharmacotherapy at Discharge — Optimization and Deprescribing

— Start with the pre-admission list, then justify every addition and every continuation

— Prefer once-daily dosing, generic, and on-formulary agents

— Use the lowest effective dose of new medications, especially in the elderly

— Avoid prescribing cascades — new symptom from a new drug? Stop the drug, don't add another

— Benzodiazepines and Z-drugs in elderly — taper, do not abruptly stop

— Anticholinergics (diphenhydramine, oxybutynin, TCAs) — falls, delirium

— PPIs without ongoing indication — reassess after 8 weeks

— Sliding-scale insulin alone — replace with basal-bolus or basal + correction

— NSAIDs in CKD, HF, or anticoagulated patients

HF with reduced EF: ARNI (or ACEi/ARB), beta-blocker (carvedilol/metoprolol succinate/bisoprolol), MRA, SGLT2i — the "four pillars," initiated before discharge whenever tolerated

Post-MI: DAPT (aspirin + P2Y12), high-intensity statin, beta-blocker, ACEi (if EF <40% or DM/HTN/CKD), nitroglycerin PRN

COPD exacerbation: LABA/LAMA ± ICS, prednisone taper to complete 5 days total, smoking cessation pharmacotherapy

Stroke/TIA: antiplatelet or anticoagulation, high-intensity statin, BP control, A1c <7%

VTE: DOAC or warfarin with bridging if indicated, clear duration (3 mo provoked, indefinite unprovoked with low bleed risk)

— Run prescriptions through formulary check before discharge — primary non-adherence due to cost is a leading driver of readmission

— Use meds-to-beds programs: prescriptions filled at hospital pharmacy delivered to bedside before discharge — reduces readmissions ~15–20%

— 340B and patient assistance programs for high-cost drugs (sacubitril/valsartan, DOACs, biologics)

Board pearl: Initiating GDMT for HFrEF before discharge (even at low doses) dramatically improves long-term adherence vs. "start as outpatient" — testable correct answer in HF readmission stems.

Principles of discharge prescribing
Deprescribing opportunities (Beers and STOPP criteria)
High-yield disease-specific discharge regimens
Cost and access considerations
Solid White Background
Procedures and Services — Care Coordination Mechanics

CPT 99495: moderate complexity, face-to-face visit within 14 days, contact within 2 business days

CPT 99496: high complexity, face-to-face within 7 days, contact within 2 business days

— Both require medication reconciliation by the date of the face-to-face visit

— Higher RVUs than standard E/M — aligns financial and quality incentives

CPT 99490: ≥20 min/month non-face-to-face for patients with ≥2 chronic conditions

— Requires patient consent, comprehensive care plan, 24/7 access to care team

— Reduces ED visits and readmissions in Medicare populations

— Must be homebound (leaving home requires considerable effort)

— Must require intermittent skilled care (nursing, PT, OT, SLP)

— Ordered by physician/NP/PA who has had face-to-face encounter within 90 days before or 30 days after start of care

— Recertification every 60 days

— Medicare Part A: requires 3-midnight qualifying inpatient stay (observation days do NOT count) — major patient safety issue, often surprises patients

— Covers up to 100 days/spell of illness; days 1–20 fully covered, 21–100 with copay

— Waived under some Medicare Advantage plans and ACO models

— Indicated for endocarditis, osteomyelitis, complicated SSTI requiring prolonged IV

— Requires PICC line, weekly labs (CBC, CMP, drug levels), ID follow-up

— Contraindicated in active IVDU without supervised model (now evolving — many centers offer OPAT to PWID with appropriate supports)

CCS pearl: When the CCS clock shows a patient ready for hospital discharge but needing IV antibiotics, ordering PICC line + ID consult for OPAT + home health + outpatient ID follow-up all together scores higher than discharging home on oral antibiotics that don't cover the organism.

Transitional Care Management (TCM) services — CMS billable
Chronic Care Management (CCM) — for ongoing complexity
Home health services (Medicare-covered if criteria met)
Skilled nursing facility (SNF) coverage
OPAT (outpatient parenteral antimicrobial therapy)
Solid White Background
Special Populations — Elderly and Renal/Hepatic Impairment

— 1 in 5 Medicare patients readmitted within 30 days

— Post-hospital syndrome especially severe: 30% have new ADL impairment vs. baseline

— Delirium during admission predicts cognitive decline and readmission

Medication review with Beers/STOPP — flag every PIM (potentially inappropriate medication)

Fall risk assessment: home safety eval by OT, remove loose rugs, install grab bars

Cognitive screen before discharge — if impaired, mandatory caregiver education and pillbox/blister pack

Hearing/vision aids in place for discharge teaching

— Advance care planning revisited — hospitalization is a sentinel event for goals-of-care conversations

— Consider PACE (Program of All-Inclusive Care for the Elderly) for nursing-home-eligible patients

— Re-dose every renally cleared medication using discharge eGFR (not admission)

— DOAC dose adjustments: apixaban (2.5 mg BID if 2 of: age ≥80, weight ≤60 kg, Cr ≥1.5), rivaroxaban contraindicated CrCl <15

— Avoid NSAIDs absolutely; counsel on OTC ibuprofen/naproxen

— Metformin: hold if eGFR <30; reassess if 30–45

— Schedule outpatient labs within 3–7 days if diuretics, ACEi/ARB, MRA, or new contrast exposure

— Lactulose titrated to 2–3 soft BMs/day — caregiver education essential

— Rifaximin for HE prophylaxis if prior episode

— SBP prophylaxis with norfloxacin/ciprofloxacin if prior SBP or ascitic protein <1.5 with renal/hepatic dysfunction

— Avoid NSAIDs, aminoglycosides, sedatives; cautious diuretic dosing with daily weights

— Hepatology follow-up within 7 days; MELD-driven transplant evaluation

Step 3 management: Cirrhotic patient discharged after HE — the answer involving caregiver-administered lactulose with rifaximin, hepatology follow-up in 7 days, and clear red-flag instructions for sleep changes or confusion beats answers focused only on medications.

The elderly patient: highest-yield population for readmission prevention
Geriatric-specific discharge interventions
Renal impairment
Hepatic impairment / cirrhosis
Solid White Background
Special Populations — Pediatrics, Pregnancy, Behavioral Health, and SDOH

— "Medical home" coordination — communicate with PCP and any specialists

— Weight-based dosing rechecked at discharge; liquid formulations with mL (not tsp)

— Car seat check for neonates and infants

— Immunization status updated — catch up before discharge if behind

— School/daycare return criteria documented

Chronic complex children: ensure all subspecialty appointments scheduled; tech-dependent kids (G-tube, trach) need equipment delivered before discharge

— Postpartum visit within 3 weeks, comprehensive visit by 12 weeks (ACOG, updated from old 6-week single visit)

— Severe-range BP (≥160/110) — readmission risk for postpartum preeclampsia/eclampsia; teach red flags (headache, vision changes, RUQ pain, dyspnea)

— Mental health screening (EPDS) — postpartum depression peaks 4–6 weeks

— Contraception counseling and provision before discharge; LARC if desired

— Breastfeeding support, lactation consult follow-up

— Warm handoff to outpatient psychiatry — appointment scheduled before discharge, not just referral

— Suicide safety planning, lethal means restriction counseling

Buprenorphine or methadone initiated inpatient for OUD reduces post-discharge mortality and readmission — bridge to outpatient MAT clinic within 72 h

— Naloxone prescribed at discharge for any patient on opioids or with OUD history

— Alcohol use disorder: naltrexone, acamprosate, or disulfiram at discharge; thiamine continued

— CMS now requires SDOH screening for inpatient encounters (Z-codes)

— Connect to: SNAP, WIC, Section 8, LIHEAP, Medicaid enrollment assistance

— IPV screening — provide safety planning resources; do not document address if shelter

Board pearl: "Discharge to address" matters: a patient experiencing homelessness discharged to "the street" with insulin and a glucometer is a foreseeable harm — the correct answer involves medical respite or shelter coordination before discharge.

Pediatric discharge planning
Postpartum and obstetric discharge
Behavioral health and substance use disorder
Social determinants of health (SDOH)
Solid White Background
Complications of Failed Transitions

— Occur in ~20% of patients in the 3 weeks post-discharge; ~70% preventable or ameliorable

— Top offenders: anticoagulants, antibiotics, opioids, insulin, cardiovascular drugs

— Mechanisms: duplicate therapy, omission, wrong dose, interaction, monitoring failure

— Example: continued home spironolactone + new ACEi → hyperkalemic arrest

— Example: warfarin restarted at home dose after antibiotic course → supratherapeutic INR, GI bleed

— ~40% of patients have pending results at discharge; up to 1/3 are clinically actionable

— Examples: blood cultures finalizing, biopsy pathology, incidental imaging findings

— Safety practice: structured pending-results section in discharge summary with named responsible clinician and tickler in EHR

— Premature closure: HF readmission turns out to be amyloidosis; "pneumonia" was actually lung cancer

— Aspiration not addressed: stroke patient sent home without swallow study clearance → recurrent pneumonia

— Failure to follow up incidentaloma → delayed cancer diagnosis (medico-legal risk)

— Falls (10–15% within 30 days), delirium, functional decline, weight loss, pressure injuries

— Caregiver burnout — sentinel event for nursing home placement

— C. difficile from inpatient antibiotics — peak onset 1–4 weeks after discharge

— CLABSI/CAUTI if lines or catheters left in

— VTE — extended prophylaxis indicated after major orthopedic, abdominopelvic cancer surgery

— Surgical site infection — typically 5–14 days post-op

Key distinction: A patient bounce-back within 72 hours usually represents premature discharge or missed diagnosis; bounce-back at 2–3 weeks usually represents failed transition (medication, follow-up, SDOH). The two require different root-cause analyses and different system fixes.

Adverse drug events (ADEs)
Missed test follow-up
Diagnostic errors uncovered post-discharge
Geriatric syndromes post-discharge
Healthcare-associated complications appearing post-discharge
Solid White Background
Escalation — When the Outpatient Transition Is Not Safe

— Unable to perform basic ADLs and no caregiver

— Active suicidal ideation with plan/intent

— Unstable housing with medical needs (insulin requiring refrigeration, oxygen)

— Suspected elder abuse, child abuse, or IPV — engage social work and protective services

— Cognitive impairment without supervision capacity

— Inability to afford or access critical medications

Inpatient rehab facility (IRF): ≥3 hr/day therapy tolerance, ≥2 disciplines, expected functional gain

Skilled nursing facility (SNF): lower-intensity rehab or skilled nursing needs

Long-term acute care hospital (LTACH): medically complex (vent weaning, complex wounds, multi-system)

Medical respite: for patients experiencing homelessness who need recovery time

Hospital-at-home: acute-level care in the home for selected stable patients

Hospice: comfort care, life expectancy ≤6 months — inpatient hospice unit, residential hospice, or home hospice with continuous care for symptom crisis

Case management/social work: any high-risk discharge, SDOH concerns, insurance navigation

Pharmacy: polypharmacy, high-risk meds, transitions involving anticoagulants/insulin/opioids

PT/OT: any functional decline from baseline, falls, equipment needs

SLP: dysphagia screen before any post-stroke or post-extubation oral diet

Palliative care: serious illness, symptom burden, goals-of-care clarification

Geriatrics consult: frailty, delirium, polypharmacy in age ≥75

— Observation status (outpatient) days do not count toward the SNF 3-midnight rule

— Patients may be surprised by bills and lose SNF coverage — communicate status clearly

— Use CMS Two-Midnight Rule for appropriate status determination

CCS pearl: When CCS clock shows a frail elder with a new oxygen requirement, no caregiver, and missed prior appointments, don't discharge home — order SNF placement, PT eval, social work, and home oxygen setup; discharge home in this scenario is scored as unsafe.

Signals that home discharge is unsafe — escalate to higher level of care
Options beyond standard home discharge
When to consult
The "observation vs. inpatient" trap
Solid White Background
Differentials — Why Did This Patient Bounce Back? (Care-Process Causes)

— Non-adherence (cost, complexity, side effects, health literacy)

— Adverse drug event (drug-drug, drug-disease, dosing error)

— Prescribing cascade

— Medication reconciliation failure at discharge

— High-risk drug class without monitoring (warfarin without INR, lithium without level, methotrexate without CBC)

— No follow-up appointment scheduled

— Appointment scheduled but patient could not attend (transportation, work, caregiver issues)

— Pending lab/imaging not followed up

— Home health ordered but not delivered

— Specialist referral made but never completed

— Patient did not understand red-flag symptoms

— Did not know which medication to hold or stop

— Could not perform required self-care (wound care, glucose monitoring, weight tracking)

— Cultural/linguistic mismatch — interpreter not used or used inadequately

— Discharge summary not transmitted in time

— PCP not informed of hospitalization

— Specialist recommendations not implemented

— Care fragmented across systems with no shared EHR

— Prior authorization or formulary issues blocked critical medications

Step 3 management: When a Step 3 stem describes a 30-day readmission, the answer choices often include both clinical intensification (more diuretic, switch antibiotic) and process improvements (pharmacist med rec, transition coach, post-discharge phone call). The latter typically wins when the failure point is clearly a transition-of-care gap.

When evaluating a readmission, frame the differential as a root-cause analysis across the care continuum
Medication-related causes (~20–30% of readmissions)
Follow-up and monitoring failures
Education and self-management failures
System-level failures
Solid White Background
Differentials — Disease-Progression vs. Care-Process Readmissions

— Roughly 25–50% of 30-day readmissions are considered preventable; the rest reflect natural disease trajectory or unrelated new illness

— HRRP penalties are risk-adjusted but imperfect — safety-net hospitals are disproportionately penalized

— End-stage HF with progressive volume overload despite optimal GDMT — consider advanced therapies (transplant, LVAD) or transition to hospice

— Advanced COPD with frequent exacerbations despite triple therapy — pulmonary rehab, palliative referral

— Decompensated cirrhosis with refractory ascites — TIPS evaluation or transplant listing

— Cancer-related: febrile neutropenia, malignant effusions, pain crises — often unavoidable

— Patient discharged after pneumonia, returns with hip fracture — not a "preventable readmission" but counted under all-cause metrics

— New diagnosis discovered during readmission (e.g., GI bleed reveals colon cancer) — sometimes the readmission is the lucky catch

— Hospital-acquired infection appearing post-discharge (C. diff, SSI, CLABSI)

— Procedure complication: post-cardiac cath bleeding, post-endoscopy perforation

— Adverse effect of inpatient medication that persists (e.g., steroid-induced psychosis)

— CMS attribution: the discharging hospital owns the readmission for HRRP purposes, regardless of cause

— Accountable Care Organizations (ACOs) and bundled payments shift incentives toward longitudinal management

Key distinction: A patient with end-stage HF readmitted 4 times in 6 months despite perfect care is not a "system failure" — it's a goals-of-care opportunity. The right answer is often palliative care consultation and advanced HF therapy discussion, not more diuretic titration.

Not every readmission is preventable
Disease-progression readmissions ("expected")
Unrelated new illness ("the unrelated bounce-back")
Iatrogenic readmissions
The system-level question: who owns the readmission?
Solid White Background
Secondary Prevention — The Longitudinal Discharge Plan

— Every discharge should anticipate and prevent the next admission

— Build the plan around the 4 Pillars (Coleman): meds, personal health record, follow-up, red flags

HF: GDMT optimization (4 pillars), daily weights, fluid <2 L, sodium <2–3 g, flu/pneumococcal/COVID vaccines, cardiac rehab, depression screen

AMI: DAPT duration clear, statin, beta-blocker, ACEi/ARB, cardiac rehab referral (Class I — under-utilized), smoking cessation, BP/lipid/glucose targets

Stroke: antiplatelet/anticoagulation, statin, BP <130/80, A1c <7%, carotid management, swallowing, post-stroke depression screening

COPD: smoking cessation pharmacotherapy + counseling, vaccines, pulmonary rehab (post-exacerbation within 4 weeks — strong evidence), action plan with rescue prednisone/antibiotic

Cirrhosis: alcohol cessation, HE prophylaxis, SBP prophylaxis if indicated, varices surveillance, HCC screening every 6 months, vaccines

Diabetes: A1c goal individualized, SGLT2i/GLP-1 if ASCVD/CKD/HF, statin, BP, foot/eye/kidney surveillance, hypoglycemia education

VTE: anticoagulation duration explicit, provoked vs. unprovoked, recurrence risk assessment

— Vaccinations updated (influenza, pneumococcal, COVID, RSV if eligible, zoster)

— Cancer screening current (mammography, colonoscopy, cervical, lung CT)

— Mental health screen (PHQ-2/9)

— Substance use review and intervention

— Advance care planning revisited

Board pearl: Cardiac rehab and pulmonary rehab are among the most under-utilized, highest-impact secondary prevention interventions on Step 3 — referring at discharge is frequently the correct answer in post-MI, post-CABG, and post-COPD-exacerbation stems.

The discharge plan IS secondary prevention
Disease-specific secondary prevention essentials
Universal secondary prevention layer
Solid White Background
Follow-Up, Monitoring, and the First 30 Days

48–72 hours: post-discharge phone call (nurse/pharmacist) — review meds, symptoms, appointments

7 days: high-risk face-to-face follow-up (HF, COPD, sepsis, post-surgical, frail elder) — CPT 99496

14 days: moderate-risk follow-up — CPT 99495

30 days: complete medication reconciliation, review pending studies, repeat labs as needed

90 days: stabilize chronic disease management, transition fully to outpatient cadence

HF: daily home weight log; clinic visit at 7 d → 2 wk → 4 wk; BMP at 1–2 weeks after diuretic/ACEi/ARNI changes; titrate GDMT every 2–4 weeks to target doses

AKI/CKD: BMP within 1 week after RAAS-inhibitor, diuretic, contrast

VTE on warfarin: INR within 3–7 days; on DOAC, follow-up at 1 month with renal function

DKA: endocrine follow-up within 1–2 weeks; verify insulin technique, glucometer use

Post-MI: cardiology 2–6 weeks, lipid panel at 4–12 weeks on statin

Post-stroke: neurology 1–3 months, BP daily home log, swallow re-eval if dysphagia

Post-op: surgeon visit at 1–2 weeks; suture/staple removal; activity progression

— Cardiac rehab post-ACS/CABG/HF — start within 1–3 weeks

— Pulmonary rehab post-COPD exacerbation — within 4 weeks

— PT/OT for any functional decline

— Diabetes self-management education (DSME) — covered by Medicare

— Smoking cessation counseling + pharmacotherapy at every visit

— Mental health referral for PHQ-9 ≥10

— HF: weight log, BP/HR log, symptom diary

— COPD: action plan, peak flow if asthma overlap

— Diabetes: SMBG or CGM logs, hypoglycemia events

— Anticoagulation: bleeding diary, medication list card

Step 3 management: "When should this newly discharged HFrEF patient be seen?" — the answer is within 7 days, in person, with BMP and weight check, and titration of GDMT initiated, not "in 4–6 weeks at routine PCP follow-up."

The standard follow-up cadence
Disease-specific monitoring parameters
Rehab and counseling referrals
Patient self-monitoring tools
Solid White Background
Ethical, Legal, and Patient Safety Considerations

— Patients have the right to leave AMA — but AMA discharge is not a free pass for the team

— Document: capacity assessment, risks explained in patient's language, alternatives offered, follow-up plan still arranged, prescriptions still given, naloxone if relevant

— AMA does not invalidate insurance coverage in most cases (common myth — do not use as coercion)

— If patient lacks capacity, AMA is not valid — engage surrogate decision-maker per state hierarchy

— Discharging a patient to a situation of foreseeable serious harm (no shelter, no caregiver, no food, no meds) can constitute patient abandonment and a Joint Commission sentinel event

— Engage social work, ethics committee, risk management when impasses arise (e.g., insurance won't cover SNF, family refuses to take patient home)

— Suspected elder abuse, child abuse, IPV (state-dependent) — Adult Protective Services, Child Protective Services

— Impaired driver concerns — state-dependent reporting to DMV (post-stroke, seizure, dementia)

— Communicable diseases — public health reporting (TB, syphilis, etc.) does not stop at discharge

— HIPAA permits sharing PHI with subsequent treating providers — push the discharge summary to PCP, SNF, home health

— Special protections: substance use treatment records (42 CFR Part 2), mental health, HIV in some states

— Patient portal access: ensure patient and authorized caregivers have it

— Joint Commission requires standardized hand-off (I-PASS, SBAR)

— Discharge to SNF/LTACH: medication list, code status, allergies, pending issues, recent vitals, baseline cognitive/functional status

— Disparities in readmission by race, ethnicity, language, SES — track and address

— Use professional interpreters (not family) for all discharge teaching when language discordant — failure is a documented safety event

Board pearl: A patient with capacity wishes to leave AMA with active endocarditis. The correct steps: assess and document capacity, explain risks, still prescribe oral antibiotics, arrange follow-up, give naloxone if PWID, and offer to readmit any time — do not punitively withhold care.

Informed discharge and capacity
"Unsafe discharge" and the duty to the patient
Mandatory reporting at discharge
Privacy and information transfer
Hand-off communication standards
Equity in discharge planning
Solid White Background
High-Yield Associations and Rapid-Fire Facts

— ~14% all-cause 30-day Medicare readmission rate

— ~25–50% of readmissions considered preventable

— Pending test results at discharge: ~40% of patients; ~10% clinically actionable

— Adverse drug events post-discharge: ~20%; ~70% preventable

— Post-hospital phone call within 72 hours and 7-day follow-up are the two single highest-yield interventions

HRRP: penalizes excess readmissions for AMI, HF, pneumonia, COPD, CABG, elective hip/knee

Hospital-Acquired Condition Reduction Program: bottom-quartile hospitals lose 1% of Medicare payments

Value-Based Purchasing: ties reimbursement to quality metrics

MSSP / ACO REACH: shared-savings models that reward longitudinal management

Bundled Payments for Care Improvement (BPCI): episode-based payment including 30/60/90-day post-discharge

— Project RED, Project BOOST, Care Transitions Intervention (Coleman), Transitional Care Model (Naylor), Interventions to Reduce Acute Care Transfers (INTERACT for SNF)

— Medication reconciliation (NPSG 03.06.01)

— Communicate accurately (hand-off)

— Use two patient identifiers

— Improve recognition and response to deteriorating patients

— Med rec with teach-back

— Follow-up scheduled before patient leaves

— Pending results assigned

— Red flags in writing

— Discharge summary to PCP within 48 h

— Cardiac rehab referral post-MI/CABG — Class I, under-utilized

— Pulmonary rehab within 4 weeks of COPD exacerbation

— Buprenorphine started inpatient for OUD reduces overdose mortality

— Influenza/pneumococcal/COVID vaccines at discharge — opportunistic

— Naloxone for any opioid prescription

Key distinction: Step 2 tests what to prescribe at discharge; Step 3 tests how to ensure the patient actually takes it, follows up, and stays out of the hospital — process measures, transition tools, and systems thinking.

Numbers worth memorizing
CMS programs to know
Evidence-based bundles
Joint Commission National Patient Safety Goals relevant to discharge
"Always-do" discharge bullet list
Special pearls
Solid White Background
Board Question Stem Patterns

— "72M with HFrEF discharged 8 days ago presents with dyspnea, 6 lb weight gain. He stopped his torsemide because he 'felt better.'"

— Trap answers: more IV diuretic alone; switch to bumetanide

— Right answer: admit, diurese, AND arrange post-discharge phone call, 7-day clinic follow-up, home health, and HF nurse education for the next discharge

— "81F on 11 medications discharged after pneumonia returns with confusion and falls"

— Trap: order CT head, MRI brain

— Right answer: pharmacist-led medication reconciliation using Beers criteria; deprescribe anticholinergics, sedatives

— "Patient discharged after pneumonia; 5 days later, blood cultures grow MRSA"

— Trap: nothing — it's the discharging team's responsibility

— Right answer: contact patient, arrange readmission or OPAT; implement systematic pending-results tracking as quality improvement

— "Post-MI patient cannot afford ticagrelor; stops both DAPT meds"

— Right answer: switch to clopidogrel (generic), patient assistance programs, meds-to-beds at discharge

— "Endocarditis patient with OUD wants to leave AMA"

— Right answer: assess capacity, harm reduction, oral antibiotics, naloxone, buprenorphine bridge, MAT clinic appointment

— "Family surprised patient does not qualify for SNF coverage"

— Right answer: patient was on observation status — does not count toward 3-midnight rule; counsel family, explore Medicaid/community options

— "Hospital wants to reduce HF 30-day readmissions"

— Right answer: implement transitional care bundle — pharmacist med rec, 72-h phone call, 7-day follow-up, home health, cardiac rehab referral

Step 3 management: When two answer choices both look "right" — one clinical, one systems-based — the systems answer wins when the failure point in the stem is clearly a transition-of-care gap.

Pattern 1 — The bounce-back vignette
Pattern 2 — The polypharmacy elder
Pattern 3 — The pending result
Pattern 4 — Cost as adherence barrier
Pattern 5 — The AMA discharge
Pattern 6 — Status confusion
Pattern 7 — Quality metric / systems
Solid White Background
One-Line Recap

Start discharge planning on day 1: identify LACE/HOSPITAL risk, engage case management, clarify destination and caregiver, anticipate barriers (cost, transportation, literacy, SDOH) before they materialize at the door

Medication reconciliation is the single highest-yield safety intervention: pharmacist-led when possible; teach-back required; meds-to-beds eliminates primary non-adherence; deprescribe using Beers/STOPP in elderly

The 72-hour phone call + 7-day in-person follow-up are the most evidence-supported transition interventions; bill as TCM (CPT 99495/99496); pair with cardiac/pulmonary rehab and home health for highest-impact bundles

Own the pending results, own the bounce-back: discharge summary to PCP within 48 hours, named responsible clinician for every pending lab or imaging finding, structured hand-off to SNF/home health using SBAR or I-PASS

Board pearl: On Step 3, when the vignette describes any recently discharged patient in trouble, ask first whether the failure was clinical (wrong drug, wrong dose, wrong diagnosis) or transitional (no follow-up, no reconciliation, no education, no support) — the correct answer almost always addresses the failure point identified, and the transitional answer is correct more often than trainees expect.

The core teaching point: A safe hospital discharge is not an endpoint but a high-risk transition of care that requires anticipatory, multidisciplinary planning, medication reconciliation, scheduled and attended follow-up, red-flag education, and longitudinal accountability — because most preventable readmissions are failures of process, not of medicine.
Top 4 recap bullets
One-line clinical mantra: "Reconcile, schedule, educate, communicate, follow up — every patient, every time."
Solid White Background
bottom of page